Uncategorized

July 30, 2025
Published by admin on July 30, 2025
Categories

OBM Was Invited by Our Legal Advisor Firm Steinepreis Paganin to Attend IPO Network’s Exclusive Event in Melbourne
30th July 2025

Oculus Biomed Limited (“OBM”) is invited by its legal advisor, Steinepreis Paganin (“SP”), to attend a function held by the IPO Network, on the evening of […]
Do you like it?2
Read more
July 27, 2025
Published by admin on July 27, 2025
Categories

OBM Attends BioAsia-Taiwan Conference and ACRO Biomedical Announces to Outlicense the Market Rights in 10 ASEAN Countries of its Biocompatible Artificial Cornea, ABCcolla Collagen Ophthalmic Matrix, to Vietnam’s CT Group
23th ~ 27 July 2025

ACRO Biomedical’s Chairman & CEO Dr Hsieh (left) & OBM’s CSO Dr Jiang (right) met for business discussion at 2025 BioAsia Taiwan Conference. ACRO Biomedical’s Chairman […]
Do you like it?2
Read more
July 14, 2025
Published by admin on July 14, 2025
Categories

Professor Mark Daniell Joined to OBM Scientific Board
14th July 2025

We highly welcome Professor Mark Daniell to join the OBM Scientific Board. He brings significant experience of medical research and clinical surgery to the company.   […]
Do you like it?3
Read more
March 14, 2025
Published by admin on March 14, 2025
Categories

Our Partner ACRO Biomedical Co., Ltd. Receives Approval for Its Biocompatible Cornea from Taiwan FDA, the Department of Health and Welfare
14th March 2025

  Our strategic partner and major shareholder, ACRO Biomedical Co., Ltd., a public listed company on Taiwan Stock Exchange and one of the Taiwan’s leading biomedical […]
Do you like it?2
Read more